Original document(10 pages) Authorized document(10 pages) 中文版
    The present invention relates to structure formula I and structure formula II ginsenoside aglycone derivative dammar-3 beta, 12 beta-dihydroxyl-20(21), 24(25)-diene, called delta 20(21)-PPD for short and dammer-3 beta, 6 alpha, 12 beta-trihydroxyl-20(21), 24(25)-diene, called delta 20(21)-PPT, specially, relates to novel anti-tumor preparation using delta 20(21)-PPD or/and delta 20(21)-PPT and containing delta 20(21)-PPD or/and delta 20(21)-PPT as active component. The delta 20(21)-PPD and delta 20(21)PPT have the anti-tumor activity of inducing tumor cell differentiation, inducing tumor cell dauth, inhibiting tumor growth, reversing tumor drugs-resistance, inhibiting tumor nascent angiogenesis, inhibiting infiltration and metastasis of tumor and raising immunity of human body, etc.
Application Number
申请号
02144776 Application Date
申请日
2002.12.13
Title 名称 Anti-tumour ginseng saponin aglycone derivatives
Publication Number
公开号
1508145 Publication Date
公开日
2004.06.30
Approval Pub. Date 2006.04.05 Granted Pub. Date 2006.04.05
International Classification 分类号 C07J9/00,A61K31/704,A61P35/00
Applicant(s) Name
申请人
Dalian Chemical Physics Inst., Chinese Academy of Sciences
Address 地址 116023
Inventor(s) Name 发明人 Yang Ling, He Kejiang
Attorney & Agent 代理人 zhang chen

  
Ginsenoside acid hydrolyzing process of preparing protopanoxadiol
Ginsenoside acid hydrolyzing process of preparing ginsenoside Rg3
Ginsenoside enzymatically hydrolyzing process to prepare 2o-beta-D-pyranoglucose protopanoxadiol
Chinese characters shape mother codes input method
Water-soluble fluorescent dye
Liquid level control system for conticaster mould
Liposome encapsulated baccatin III derivative and its usage
Self-emulsifying composition of beta-11 betamethasone, preparation process and application thereof
Communication process system and its method, and time measuring device between network element
Microorganism capable of hydrolyzing glycosyl to hydroxyl and application thereof
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.